Rodriguez Arrieta, L.A. et al. 2025. When skin reactions interrupt bone therapy: severe cutaneous adverse reaction to romosozumab leading to treatment discontinuation. European Journal of Case Reports in Internal Medicine. 12, 9 (Aug. 2025). DOI:https://doi.org/10.12890/2025_05719.